WHO Offers PIC/S, Other Regulatory Assistance To China
This article was originally published in PharmAsia News
The World Health Organization has signed a "regulatory cooperation plan" with the China Food and Drug Administration intended to help the CFDA strengthen its regulatory capabilities and to reinforce existing ties between the two organizations in a wide range of areas.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.